참고문헌
- Bowen RL, Stebbing J, Jones LJ (2006), A review of the ethnic differences in breast cancer. Pharmacogenomics, 7, 935-42. https://doi.org/10.2217/14622416.7.6.935
- Brenton JD, Carey LA, Ahmed AA, Caldas C (2005), Molecular classification and molecular forecasting of breast cancer: ready for clinical application?. J Clin Oncol, 23, 7350-60. https://doi.org/10.1200/JCO.2005.03.3845
- Brouckaert O, Laenen A, Vanderhaegen J, et al (2012), Applying the 2011 St Gallen panel of prognostic markers on a large single hospital cohort of consecutively treated primary operable breast cancers. Ann Oncol, 23, 2578-84. https://doi.org/10.1093/annonc/mds062
- Chen CH, Lo YF, Tsai HP, et al (2009), Low body mass index is an independent risk factor of locoregional recurrence in women with breast cancer undergoing breast conserving therapy. Chang Gung Med J, 32, 553-62.
- Chen K, Zeng YH, Jia W, et al (2012), Clinical outcomes of breast-conserving surgery in patients using a modified method for cavity margin assessment. Ann Surg Oncol, 19, 3386-94. https://doi.org/10.1245/s10434-012-2331-5
- Clark RM, Whelan T, Levine M et al (1996), Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. Ontario Clinical Oncology Group. J Natl Cancer Inst, 88, 1659-64. https://doi.org/10.1093/jnci/88.22.1659
- Cuzick J, Dowsett M, Pineda S, et al (2011), Prognostic value of a combined estrogen receptor, progesterone receptor, Ki-67, and human epidermal growth factor receptor 2 immunohistochemical score and comparison with the Genomic Health recurrence score in early breast cancer. J Clin Oncol, 29, 4273-8. https://doi.org/10.1200/JCO.2010.31.2835
- Dent R, Trudeau M, Pritchard KI, et al (2007), Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res, 13, 4429-34. https://doi.org/10.1158/1078-0432.CCR-06-3045
- Ewertz M, Jensen MB, Gunnarsdottir KA, et al (2011), Effect of obesity on prognosis after early-stage breast cancer. J Clin Oncol, 29, 25-31. https://doi.org/10.1200/JCO.2010.29.7614
- Fan L, Zheng Y, Yu KD, et al (2009), Breast cancer in a transitional society over 18 years: trends and present status in Shanghai, China. Breast Cancer Res Treat, 117, 409-16. https://doi.org/10.1007/s10549-008-0303-z
- Fisher B, Anderson S, Redmond CK, et al (1995), Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med, 333, 1456-61. https://doi.org/10.1056/NEJM199511303332203
- Fisher B, Jeong JH, Anderson S, et al (2002), Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med, 347, 567-75. https://doi.org/10.1056/NEJMoa020128
- Forrest AP, Stewart HJ, Everington D, et al (1996), Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial. Scottish Cancer Trials Breast Group. Lancet, 348, 703-13.
- Goldhirsch A, Wood WC, Coates AS, et al (2011), Strategies for subtypes--dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol, 22, 1736-47. https://doi.org/10.1093/annonc/mdr304
- Haffty BG, Yang Q, Reiss M, et al (2006), Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer. J Clin Oncol, 24, 5652-7. https://doi.org/10.1200/JCO.2006.06.5664
- Bland KI, Menck HR, Scott-Conner CE, et al (2009), The National Cancer Data Base 10-year survey of breast carcinoma treatment at hospitals in the United States. Cancer, 83, 1262-73.
- Jones HA, Antonini N, Hart AA, et al (2009), Impact of pathological characteristics on local relapse after breastconserving therapy: a subgroup analysis of the EORTC boost versus no boost trial. J Clin Oncol, 27, 4939-47. https://doi.org/10.1200/JCO.2008.21.5764
- Kim HJ, Han W, Yi OV, et al (2011), Young age is associated with ipsilateral breast tumor recurrence after breast conserving surgery and radiation therapy in patients with HER2-positive/ER-negative subtype. Breast Cancer Res Treat, 130, 499-505. https://doi.org/10.1007/s10549-011-1736-3
- Kim KJ, Huh SJ, Yang JH, et al (2005), Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy. Jpn J Clin Oncol, 35, 126-33. https://doi.org/10.1093/jjco/hyi039
- Hsu JL, Glaser SL, West DW (1997), Racial/ethnic differences in breast cancer survival among San Francisco Bay Area women. J Natl Cancer Inst, 89, 1311-2. https://doi.org/10.1093/jnci/89.17.1311
- Li J, Zhang BN, Fan JH, et al (2011), A nation-wide multicenter 10-year (1999-2008) retrospective clinical epidemiological study of female breast cancer in China. BMC Cancer, 11, 364. https://doi.org/10.1186/1471-2407-11-364
- Li S, Yu KD, Fan L, Hou YF, Shao ZM (2011), Predicting breast cancer recurrence following breast-conserving therapy: a single-institution analysis consisting of 764 Chinese breast cancer cases. Ann Surg Oncol, 18, 2492-9. https://doi.org/10.1245/s10434-011-1626-2
- Miles RC, Gullerud RE, Lohse CM, et al (2012), Local recurrence after breast-conserving surgery: multivariable analysis of risk factors and the impact of young age. Ann Surg Oncol, 19, 1153-9. https://doi.org/10.1245/s10434-011-2084-6
- Millar EK, Graham PH, O'Toole SA, et al (2009), Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early-stage invasive breast cancer using a five-biomarker panel. J Clin Oncol, 27, 4701-8. https://doi.org/10.1200/JCO.2008.21.7075
- Renton SC, Gazet JC, Ford HT, et al (1996), The importance of the resection margin in conservative surgery for breast cancer. Eur J Surg Oncol, 22, 17-22. https://doi.org/10.1016/S0748-7983(96)91253-6
- Sorlie T, Perou CM, Tibshirani R, et al (2001), Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA, 98, 10869-74. https://doi.org/10.1073/pnas.191367098
- Sparano JA, Wang M, Zhao F, et al (2012), Obesity at diagnosis is associated with inferior outcomes in hormone receptorpositive operable breast cancer. Cancer, 118, 5937-46. https://doi.org/10.1002/cncr.27527
- van der Leij F, Elkhuizen PH, Bartelink H, van de Vijver MJ (2012), Predictive factors for local recurrence in breast cancer. Semin Radiat Oncol, 22, 100-7. https://doi.org/10.1016/j.semradonc.2011.12.001
- Veronesi U, Cascinelli N, Mariani L, et al (2002), Twentyyear follow-up of a randomized study comparing breastconserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347, 1227-32. https://doi.org/10.1056/NEJMoa020989
- Voduc KD, Cheang MC, Tyldesley S, et al (2010), Breast cancer subtypes and the risk of local and regional relapse. J Clin Oncol, 28 1684-91. https://doi.org/10.1200/JCO.2009.24.9284
- Yang H, Jia W, Chen K, et al (2012), Cavity margins and lumpectomy margins for pathological assessment: which is superior in breast-conserving surgery?. J Surg Res, 178, 751-7. https://doi.org/10.1016/j.jss.2012.05.030
- Yau TK, Soong IS, Chan K, et al (2007), Clinical outcome of breast conservation therapy for breast cacner in Hong Kong: prognostic impact of ipsilateral breast tumor recurrence and 2005 St. Gallen risk categories. Int J Radiat Oncol Biol Phys, 68, 667-72. https://doi.org/10.1016/j.ijrobp.2006.12.043
피인용 문헌
- Oncoplastic Breast Conserving Surgery with Nipple-areolar Preservation for Centrally Located Breast Cancer: a Retrospective Cohort Study vol.15, pp.12, 2014, https://doi.org/10.7314/APJCP.2014.15.12.4847
- Benefit of Post-mastectomy Radiotherapy of the Supra-/infraclavicular Lymphatic Drainage Area in Breast Cancer Patients vol.15, pp.14, 2014, https://doi.org/10.7314/APJCP.2014.15.14.5557
- Clinicopathological Features of Indonesian Breast Cancers with Different Molecular Subtypes vol.15, pp.15, 2014, https://doi.org/10.7314/APJCP.2014.15.15.6109
- Fulvestrant 250mg versus Anastrozole 1 mg in the Treatment of Advanced Breast Cancer: a Meta-Analysis of Randomized Controlled Trials vol.15, pp.5, 2014, https://doi.org/10.7314/APJCP.2014.15.5.2095
- Is Interleukin 10 (IL10) Expression in Breast Cancer a Marker of Poor Prognosis? vol.7, pp.3, 2016, https://doi.org/10.1007/s13193-016-0512-6